The head of the Food and Drug Administration’s drug center abruptly resigned Sunday amid concerns about his personal conduct. A federal spokesperson said Dr.

Company’s first metered-dose inhalation (MDI) product and establishes a new growth vector for the Affordable Medicines ...

How often have you heard the argument that abortion should remain legal because, otherwise, women would resort to dangerous back-alley abortions? This is the so-called clothes-hanger argument, […] ...

How often have you heard the argument that abortion should remain legal because, otherwise, women would resort to dangerous ...

The approval was based on the phase 3 ZENITH trial, which evaluated sotatercept in PAH adults aged 18 years and older with WHO FC II or IV at high risk of mortality.

The approval for the CRSwNP indication was based on data from the randomized, double-blind, placebo-controlled WAYPOINT trial.

Among them, Lucentis® is the first anti-vascular endothelial growth factor (VEGF) drug approved for ophthalmic use in China, and has accumulated mature clinical application experience, providing ...

PvPI identifies 16 India specific signals, 183 drug safety alerts towards patient safety: Shardul Nautiyal, Mumbai Monday, October 27, 2025, 08:00 Hrs [IST] The Pharmacovigilance ...

The Food and Drug Administration (FDA) has approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory ...

Investigational treatment with zenocutuzumab-zbco in adults with advanced unresectable or metastatic NRG1+ cholangiocarcinoma showed a 37% ORR, median time to response of 1.9 months, and median ...